18-02-2022 14:00 via wallstreet-online.de

Moderna Expands Its mRNA Pipeline with Three New Development Programs

mRNA-1608 is a vaccine candidate against Herpes simplex virus (HSV)mRNA-1468 is a vaccine candidate against varicella-zoster virus (VZV) to reduce the rate of herpes zoster (shingles)mRNA-4359 is a new checkpoint cancer vaccineCAMBRIDGE, MA / …
Weiterlesen »